SAGE Therapeutics

Sage’s epilepsy drug fails to do better than placebo in key clinical trial
Sage’s epilepsy drug fails to do better than placebo in key clinical trial
Stat
SAGE Therapeutics
epilepsy
clinical trials
brexanolone
Flag link:
Sage Therapeutics reports 4Q loss
Sage Therapeutics reports 4Q loss
Yahoo/AP
SAGE Therapeutics
earnings
Flag link:
Sage Therapeutics Leads Biotech Movers on False Takeout Rumors
Sage Therapeutics Leads Biotech Movers on False Takeout Rumors
TheStreet.com
SAGE Therapeutics
M&A
Flag link:
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Yahoo/24-7 Wall St
SAGE Therapeutics
major depressive disorder
SAGE-217
Flag link:
The FDA just signed off on a Formula 1 pivotal track for Sage’s postpartum depression drug
The FDA just signed off on a Formula 1 pivotal track for Sage’s postpartum depression drug
Endpoints
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
Flag link:
Sage Therapeutics shares surge 45% on positive trial of postpartum depression drug
Sage Therapeutics shares surge 45% on positive trial of postpartum depression drug
Marketwatch
SAGE Therapeutics
SAGE-547
postpartum depression
Flag link:
Sage Therapeutics, Inc: Overhyped Lead Drug Headed For Failure
Sage Therapeutics, Inc: Overhyped Lead Drug Headed For Failure
Seeking Alpha
SAGE Therapeutics
SAGE-547
super-refractory status epilepticus
SRSE
Flag link:
Sage Therapeutics reports 4Q loss
Sage Therapeutics reports 4Q loss
Yahoo/AP
SAGE Therapeutics
earnings
Flag link:
Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study
Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study
TheStreet.com
SAGE Therapeutics
SAGE-547
essential tremors
Flag link:
Sage Therapeutics reports 2Q loss
Sage Therapeutics reports 2Q loss
Yahoo/AP
SAGE Therapeutics
earnings
Flag link:
Sage gets a peek at success treating postpartum depression, and its shares soar
Sage gets a peek at success treating postpartum depression, and its shares soar
Fierce Biotech
SAGE Therapeutics
postpartum depression
SAGE-547
Flag link:
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug
Forbes
ASCO
cystic fibrosis
neratinib
Puma Biotechnology
Bluebird Bio
SAGE Therapeutics
Orkambi
Vertex Pharmaceuticals
Flag link:
Sage Therapeutics reports 1Q loss
Sage Therapeutics reports 1Q loss
Yahoo/AP
SAGE Therapeutics
earnings
Flag link:
The Coming Boom In Brain Medicines
The Coming Boom In Brain Medicines
Forbes
Yumanity Therapeutics
SAGE Therapeutics
Acadia
Naurex
brain research
Flag link:
Biotech upstart Sage sees early efficacy for rare brain seizure drug
Biotech upstart Sage sees early efficacy for rare brain seizure drug
Fierce Biotech
SAGE Therapeutics
SAGE-547
Flag link:
Severe Epileptic Patients in Coma Respond to Sage Therapeutics Experimental Drug
Severe Epileptic Patients in Coma Respond to Sage Therapeutics Experimental Drug
TheStreet.com
epilepsy
SAGE Therapeutics
SAGE-547
Flag link:
2014's most successful biotech IPOs
2014's most successful biotech IPOs
Fierce Biotech
IPOs
biotech
Ultragenyx
ZS Pharma
Auspex Pharmaceuticals
Avalanche Biotechnologies
SAGE Therapeutics
Kite Pharma
Otonomy
Zafgen
ProQR
Radius Health
Flag link:
Sage soars after banking $90M in an up-sized IPO
Sage soars after banking $90M in an up-sized IPO
Fierce Biotech
SAGE Therapeutics
CNS
IPOs
Flag link:
Sage's $60M swing is the next big test of biotech's IPO window
Sage's $60M swing is the next big test of biotech's IPO window
Fierce Biotech
IPOs
biotech
SAGE Therapeutics
Flag link:
Third Rock Ventures launches new biotech, SAGE Therapeutics
Third Rock Ventures launches new biotech, SAGE Therapeutics
Bizjournals.com
SAGE Therapeutics
Third Rock
CNS
Flag link: